We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.

Delisted

APEN was delisted on the 3rd of April, 2023.

35 hedge funds and large institutions have $29.7M invested in Apollo Endosurgery, Inc. in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% less funds holding

Funds holding: 3835 (-3)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

27% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 11

54% less capital invested

Capital invested by funds: $64.4M → $29.7M (-$34.7M)

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
35
Holders Change
-3
Holders Change %
-7.89%
% of All Funds
0.78%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
7
Increased
8
Reduced
11
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
1
Stonepine Capital Management
Oregon
$7.54M -$1.94M -392,570 -15%
NCM
2
Nantahala Capital Management
Connecticut
$6.07M +$2.81M +568,577 +48%
CI
3
CPMG Inc
Texas
$4.39M
GS
4
Gagnon Securities
New York
$2.94M +$2.43M +491,703 +137%
Luther King Capital Management (LKCM)
5
Luther King Capital Management (LKCM)
Texas
$1.89M
GA
6
Gagnon Advisors
New York
$1.79M +$1.33M +268,790 +107%
Russell Investments Group
7
Russell Investments Group
United Kingdom
$1.26M -$223K -45,200 -11%
Vanguard Group
8
Vanguard Group
Pennsylvania
$595K -$1.47M -297,624 -63%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$425K +$32.3K +6,551 +6%
Goldman Sachs
10
Goldman Sachs
New York
$415K +$593K +120,200 New
NSEDCP
11
NJ State Employees Deferred Compensation Plan
New Jersey
$414K +$19.8K +4,000 +3%
WVP
12
Worth Venture Partners
New Jersey
$368K +$281K +57,000 +114%
BCM
13
Bridgeway Capital Management
Texas
$273K
Renaissance Technologies
14
Renaissance Technologies
New York
$256K -$55.8K -11,300 -13%
FPC
15
Falcon Point Capital
California
$219K -$64.9K -13,151 -17%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$215K
AAP
17
Ardsley Advisory Partners
Connecticut
$167K -$8.01K -1,623 -3%
Northern Trust
18
Northern Trust
Illinois
$104K
BlackRock
19
BlackRock
New York
$81K -$2.09K -424 -2%
WIC
20
Woodmont Investment Counsel
Tennessee
$69K -$15.4K -3,115 -13%
UOTTAIMCU
21
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$54K
SFS
22
Strategic Financial Services
New York
$47K +$67.2K +13,600 New
Millennium Management
23
Millennium Management
New York
$41K +$58.2K +11,781 New
UBS Group
24
UBS Group
Switzerland
$16K -$12.2K -2,469 -35%
Macquarie Group
25
Macquarie Group
Australia
$7K +$9.38K +1,900 New

APEN Hedge Fund Activity: Q4 2018 in Review

35 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q4 2018, worth a combined $29.7M — down 54% from $64.4M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of APEN and 7 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 8 added.

The largest buyer was Nantahala Capital Management, adding an estimated $2.81M. The largest seller was Cortina Asset Management, exiting entirely with an estimated $3.97M sold.

  • 35 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q4 2018, down from 38 in Q3 2018.
  • Funds reported $29.7M of Apollo Endosurgery, Inc. stock for Q4 2018, down 54% quarter-over-quarter.
  • 7 funds opened new Apollo Endosurgery, Inc. positions in Q4 2018 and 8 closed out, a net change of -1 holder.
  • The largest Apollo Endosurgery, Inc. buyer in Q4 2018 was Nantahala Capital Management, an estimated $2.81M added.
  • The largest Apollo Endosurgery, Inc. seller in Q4 2018 was Cortina Asset Management, an estimated $3.97M sold.

Based on aggregated 13F filings for Q4 2018.